Skip to main content
Back

ISO 10993-18:2020

Biological evaluation of medical devices -- Part 18: Chemical characterization of medical device materials within a risk management process

General information

Valid from 13.01.2020
Directives or regulations
None

Standard history

Status
Date
Type
Name
11.05.2022
Amendment
13.01.2020
Main
30.06.2005
Main
This document specifies a framework for the identification, and if necessary, quantification of constituents of a medical device, allowing the identification of biological hazards and the estimation and control of biological risks from material constituents, using a generally stepwise approach to the chemical characterization which can include one or more of the following:
-  the identification of its materials of construction (medical device configuration);
-  the characterization of the materials of construction via the identification and quantification of their chemical constituents (material composition);
-  the characterization of the medical device for chemical substances that were introduced during manufacturing (e.g. mould release agents, process contaminants, sterilization residues);
-  the estimation (using laboratory extraction conditions) of the potential of the medical device, or its materials of construction, to release chemical substances under clinical use conditions (extractables);
-   the measurement of chemical substances released from a medical device under its clinical conditions of use (leachables).
This document can also be used for chemical characterization (e.g. the identification and/or quantification) of degradation products. Information on other aspects of degradation assessment are covered in ISO 10993-9, ISO 10993-13, ISO 10993-14 and ISO 10993-15.
The ISO 10993 series is applicable when the material or medical device has direct or indirect body contact (see ISO 10993-1 for categorization by nature of body contact).
This document is intended for suppliers of materials and manufacturers of medical devices, to support a biological evaluation.

Required fields are indicated with *

*
*
*
PDF
254.36 € incl tax
Paper
254.36 € incl tax
Standard monitoring

Customers who bought this item also bought

Main

ISO/TS 10993-19:2020

Biological evaluation of medical devices -- Part 19: Physico-chemical, morphological and topographical characterization of materials
Newest version Valid from 12.03.2020
Main

ISO 10993-15:2019

Biological evaluation of medical devices -- Part 15: Identification and quantification of degradation products from metals and alloys
Newest version Valid from 26.11.2019
Main

ISO 10993-9:2019

Biological evaluation of medical devices -- Part 9: Framework for identification and quantification of potential degradation products
Newest version Valid from 26.11.2019
Amendment

EVS-EN ISO 11135:2014/A1:2019

Sterilization of health-care products - Ethylene oxide - Requirements for the development, validation and routine control of a sterilization process for medical devices - Amendment 1: Revision of Annex E, Single batch release (ISO 11135:2014/Amd 1:2018)
Newest version Valid from 02.12.2019